Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001722024-20-000007
Filing Date
2020-07-15
Accepted
2020-07-15 20:32:04
Documents
1
Period of Report
2020-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_159485950986812.html 3  
1 FORM 3 wf-form3_159485950986812.xml 3 5208
  Complete submission text file 0001722024-20-000007.txt   6799
Mailing Address 26 NORTH EUCLID AVENUE PASADENA CA 91101
Business Address 26 NORTH EUCLID AVENUE PASADENA CA 91101 626-578-0777
Alexandria Venture Investments, LLC (Reporting) CIK: 0001722024 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39385 | Film No.: 201030522

Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Issuer) CIK: 0001812364 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)